Found 66 matching trials
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Melanoma PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Inserting a gene that has been created in the laboratory into a ...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Learn More & Join Trial
Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma PHASE2 This randomized pilot phase II trial studies how well vaccine therapy works...
Show More Location
Providence Portland Medical Center
Learn More & Join Trial
Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. EARLY_PHASE1 Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Show More Location
Biogenea Pharmaceuticals Ltd
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Metastatic Melanoma PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
Melanoma Vaccine With Peptides and Leuprolide PHASE2 The goal of this clinical research study is to learn if the drug leuprolide...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma PHASE2 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Learn More & Join Trial
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma PHASE1 RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma PHASE2 This randomized phase II trial is studying how well giving vaccine therapy ...
Show More Location
National Cancer Institute Surgery Branch
Learn More & Join Trial